CompletedPhase 3

The StoneBreakerTM Trial

Canada40 participantsStarted 2008-02

Plain-language summary

The purpose of this study is to compare the LMA StoneBreakerTM to the current standard of pneumatic lithotripsy, the Swiss LithoClastR, during percutaneous nephrolithotripsy (PNL).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over the age of 18 undergoing PNL * Previously untreated renal stones * Patients with 3 or less individual renal calculi, accessible with a rigid nephroscope * Stones must be at least \>225mm2 area on KUB * Patient must have a CT scan prior to treatment Exclusion Criteria: * Patients with an active contraindication for PNL (pregnancy, uncorrected coagulopathy, active urinary infection, contrast allergy) * Partial staghorn calculi * Complete staghorn calculi * Stones in calyceal diverticulum * Cases requiring multiple tracts

What they're measuring

Time to complete fragmentation of renal calculi treated via PNL

Timeframe: During surgery

Trial details

NCT IDNCT00677196

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-09

View on ClinicalTrials.gov More Percutaneous Nephrolithotripsy trials